Tags : Adalloce

Biosimilars

Samsung Bioepis and Yuhan Collaborate for the Commercialization of Adalloce

Shots: Samsung Bioepis enter into a marketing collaboration with Yuhan Corporation for the domestic sale of Adalloce in Korea to treat RA, AS, and CD Additionally, Samsung Bioepis is conducting domestic sales of Etoloce (biosimilar, enbrel) and Remaloce (biosimilar, Remicade), which have been previously released, through Yuhan Corporation Based on the contract, the cooperation between […]Read More